Showing posts with label corticosteroid. Show all posts
Showing posts with label corticosteroid. Show all posts

Friday, 31 December 2010

Asthma victims can benefit from steroids

According to a new study by researchers at Washington University School of Medicine and other institutions, asthmatics can benefit to a significant extent when doses of steroids are increased or more drugs are added to the steroid treatment.
Robert C. Strunk, M.D., and Leonard B. Bacharier, M.D., both Washington University pediatric asthma specialists at St. Louis Children's Hospital were co-authors for this study.
"We used a few complicated and expensive tests we thought would help us determine which drug would be better, but they didn't help, so we can avoid these tests," says Strunk, the Donald Strominger Professor of Pediatrics at Washington University School of Medicine.
Although 98 percent of patients in the study showed improvement on at least one of the step-up options, there were still 120 asthma exacerbations, or attacks, among the 165 patients that required treatment with prednisone, a corticosteroid commonly used after an exacerbation that prevents the release of inflammatory substances in the body. Bacharier says that indicates none of these treatments provide perfect asthma control.
"There may not be an ideal therapy for every patient, but these step-up treatments allow for improved asthma control and outcomes over leaving them on low-dose steroids alone," Bacharier says.
This study was published online March 2, 2010, by the New England Journal of Medicine and presented the same day at the American Academy of Allergy, Asthma and Immunology's annual meeting in New Orleans.

Monday, 16 August 2010

Injectable steroids demonstrate efficacy for treating diabetic complications

Triamcinolone (a corticosteroid), when injected directly into the eye, for treating progression of a complication of diabetes, diabetic retinopathy can be more than just useful, according to a study.
The finding was disclosed in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Corticosteroids have been shown to interfere with the creation of new blood vessels, possibly by reducing the production of compounds that spur their growth, the authors note. However, steroids are also associated with other eye diseases.
"Use of this intravitreal [injected into the eye] corticosteroid preparation to reduce the likelihood of progression of retinopathy is not warranted at this time because of the increased risk of glaucoma and cataract associated with intravitreal steroid use," the authors write. "Any treatment to be used routinely to prevent proliferative diabetic retinopathy likely needs to be relatively safe because the condition already can be treated successfully and safely with panretinal photocoagulation. Nevertheless, further investigation with regard to the role of pharmacotherapy for reduction of the incidence of progression of retinopathy appears to be warranted."
The finding was revealed after a study involving 840 eyes of 693 participants having macular edema was conducted by Neil M. Bressler, M.D., of Johns Hopkins University School of Medicine, Baltimore, and colleagues in the Diabetic Retinopathy Clinical Research Network.

Monday, 24 May 2010

Asthma drug combo or increase in steroid doses can bring improvement

Children with asthma and continuing to experience the disease symptoms and making use of use of low-dose inhaled corticosteroids can find benefit by or adding one of two asthma drugs or increasing the dosage.
Results of the study, called BADGER (Best ADd-on therapy Giving Effective Responses) can help physicians in predicting, in a better way, as to which of the options would help a patient the most.
Surprisingly, researchers determined several factors that had no influence on a drug's effectiveness, including age, gender, allergies, bronchodilator response, recent exacerbations or several other tests.
"We used a few complicated and expensive tests we thought would help us determine which drug would be better, but they didn't help, so we can avoid these tests," says Strunk, the Donald Strominger Professor of Pediatrics at Washington University School of Medicine.
Although 98 percent of patients in the study showed improvement on at least one of the step-up options, there were still 120 asthma exacerbations, or attacks, among the 165 patients that required treatment with prednisone, a corticosteroid commonly used after an exacerbation that prevents the release of inflammatory substances in the body. Bacharier says that indicates none of these treatments provide perfect asthma control.
"There may not be an ideal therapy for every patient, but these step-up treatments allow for improved asthma control and outcomes over leaving them on low-dose steroids alone," Bacharier says.
Robert C. Strunk, M.D., and Leonard B. Bacharier, M.D., both Washington University pediatric asthma specialists at St. Louis Children's Hospital, were coauthors on the study, published online March 2, 2010, by the New England Journal of Medicine.

Friday, 16 April 2010

Steroids do not show efficacy for treating tennis elbow

Steroid injections are not effective for treating tennis elbow, as per a new study in the BMJ. The study also suggested that a wait-and-watch approach is the best option before any medical advice or medication can be recommended.
The study findings suggested that tennis elbow is a self-limiting condition in most of the cases.
Initially, corticosteroid injections were the most successful treatment, with 78% of those in the group reporting improvements, followed closely by physiotherapy with a 65% success rate when compared to just 27% in the 'wait and see' group.
However, after 52 weeks the injection group rates of improvement were significantly worse than those of the physiotherapy group. The injection group also had the most reported recurrences, with 72% of participants' condition deteriorating after three or six weeks – which could be due, in part, to a quicker initial recovery leading to greater use and over-taxing of the elbow.
The research also found that the superior long-term effects of physiotherapy were replicated by the wait and see approach – at the end of the study participants in both the physiotherapy and wait and see group had either much improved or completely recovered.
The authors say that "the…poor overall performance of corticosteroid injections should be taken under consideration by both the patient and their doctor in management of tennis elbow."
It is believed that the finding would provide new insights to medical practitioners for treating individuals suffering from tennis elbow.

Tuesday, 9 March 2010

Decline of lung function can be halted with Vitamin D

Vitamin D emerges as an effective option for slowing down the progressive decline in the ability to breathe in asthmatic people due to human airway smooth muscle (HASM) proliferation.
The finding was reported by researchers at the University of Pennsylvania. It was remarked by the researchers that calcitriol, a form of vitamin D synthesized within the body, can prove effective to reduce growth-factor-induced HASM proliferation in cells isolated from both persons with asthma and from persons without the disease.
"Calcitriol has recently earned prominence for its anti-inflammatory effects," said Gautam Damera, Ph.D., who will present the research at the American Thoracic Society's 105th International Conference in San Diego on May 20. "But our study is the first to reveal the potent role of calcitriol in inhibiting ASM proliferation."
The experiments were conducted with cells from 12 subjects, and the researchers compared calcitriol with dexmethasone, a corticosteroid prescribed widely for the treatment of asthma. Although, dexmethasone is also a powerful anti-inflammatory agent, the researchers found that it had little effect on HASM growth.
Dr. Damera and his colleagues found calcitriol inhibits HASM in a dose-dependent manner, with a maximum inhibitory effect of 60 percent ± 3 percent at 100nM.
The irreversible decline in breathing leading to vulnerable health in asthmatics is possible of being prevented or forestalled by slowing airway remodeling, as per the researchers.


Monday, 28 December 2009

Diabetes-related eye diseases may be treated with steroids

According to a new study that was led by researcher Dr Neil M. Bressler of Johns Hopkins University School of Medicine, steroids when injected directly into the eye can help in treating Diabetic retinopathy, which is a complication of diabetes and results in vision loss and blindness.
Proliferative diabetic retinopathy occurs when new blood vessels are formed on the optic disc or another component of the retina. The study highlighted that there is a need for further studies in identifying other treatment though laser treatments may reduce the risk of vision loss while control of blood glucose can prevent the development of retinopathy.
"Use of this intravitreal [injected into the eye] corticosteroid preparation to reduce the likelihood of progression of retinopathy is not warranted at this time because of the increased risk of glaucoma and cataract associated with intravitreal steroid use," the authors write.
"Any treatment to be used routinely to prevent proliferative diabetic retinopathy likely needs to be relatively safe because the condition already can be treated successfully and safely with panretinal photocoagulation.
“Nevertheless, further investigation with regard to the role of pharmacotherapy for reduction of the incidence of progression of retinopathy appears to be warranted," they added.
The study appeared in journal Archives of Ophthalmology, one of the JAMA/Archives journals.

Saturday, 25 July 2009

Steroids help in faster recovery from pneumonia

Corticosteroids are often used to treat inflammation caused by infectious diseases such as bacterial meningitis. In a study published in an issue of Journal of Infectious Diseases, a team of researchers show that subsequent treatment of steroids and antibiotics will produce faster recovery and lesser inflammation in the lungs of mice infected with a type of severe bacterial pneumonia.

According to Dr. Robert Hardy, the study's senior author and an associate professor of internal medicine and pediatrics, some people may think that steroids given together with antibiotic would counteract the latter's effect. But their study proved otherwise. It turned out that antibiotic will only kill the bacteria but adding corticosteroid will help reduce inflammation in the lungs. The steroids will not kill the bacteria, but it will sure help in a faster recovery and restoration of health.

Mice were utilized during the study and were divided into three groups. Each group will receive placebo drugs, antibiotics, or a combination of antibiotic and steroid in order to investigate the effect of the bacteria on airway inflammation. The group which recovered faster was the one treated with a combination therapy. It was concluded by the researchers that adding corticosteroid to traditional antimicrobial therapy might help patients with pneumonia recover faster than antibiotics alone.

From Medical News Today:
"Some people might think that if you give steroids, it would counteract the effect of the antibiotic," said Dr. Robert Hardy, associate professor of internal medicine and pediatrics and the study's senior author. "But it turns out you need the antibiotic to kill the bug and the steroid to make the inflammation in the lung from the infection get better. The steroids don't kill the bugs, but they do help restore health."